Several attempts have been made to refine selection criteria for cardiac resynchronisation therapy (CRT) in heart failure patients with reduced ejection fraction (HFrEF). Previously proposed parameters probably do not sufficiently reflect the underlying mechanical dyssynchrony of the left ventricle (LV). Earlier work of our research group suggests that better candidate selection can rely on the direct observation or measurement of this LV mechanical dyssynchrony by means of non-invasive imaging. In this study apical rocking and other non-invasive measures of LV mechanical dyssynchrony will be applied to evaluate regional myocardial workload and metabolism, and determine their predictive value in CRT response.
Study Type
INTERVENTIONAL
Enrollment
200
Universitaire Ziekenhuizen Leuven
Leuven, Belgium
Oslo University Hospital
Oslo, Norway
Cardiac resynchronisation therapy (CRT) response assessed by echocardiography
Reduction in LVESV ≥15% from baseline
Time frame: Change of left ventricular end-systolic volume (LVESV) between baseline and 6 months after CRT implantation
CRT response assessed by echocardiography
Reduction in LVESV ≥15% from baseline
Time frame: Change of LVESV between baseline and 12 months after CRT implantation
Reverse left ventricular remodelling measured as changes in left ventricular volume by echocardiography
Measured as changes in left ventricular volume by echocardiography
Time frame: Change of remodelling between baseline, 6 and 12 months after CRT implantation
Reverse left ventricular remodelling measured as changes in left ventricular ejection fraction by echocardiography
Measured as changes in left ventricular ejection fraction by echocardiography
Time frame: Change of remodelling between baseline, 6 and 12 months after CRT implantation
New York Heart Association (NYHA) class changes
A decrease of ≥1 NYHA class
Time frame: Change of NYHA class between baseline, 6 and 12 months after CRT implantation
Functional capacity changes assessed by 6-minute walking test
Assessed by 6-minute walking test
Time frame: Change of functional capacity between baseline and 6 months after CRT implantation
Functional capacity changes assessed by peak oxygen uptake ergospirometry (VO2max)
Assessed by peak oxygen uptake ergospirometry (VO2max)
Time frame: Change of functional capacity between baseline and 6 months after CRT implantation
Quality of Life changes
Time frame: Change of QoL between baseline, 6 and 12 months after CRT implantation
Heart failure related hospital admissions
Time frame: Assessment of the number of hospital admissions at 6 and 12 months after CRT implantation
Death
Death by heart failure, sudden cardiac death and all-cause death
Time frame: Assessment of possible death at 6 and 12 months after CRT implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.